Cargando…

Pulmonary Embolism in COVID-19 Patients: Which Diagnostic Algorithm Should We Use?

Introduction: Although pulmonary embolism (PE) is a frequent complication of the clinical course of COVID-19, there is a lack of explicit indications regarding the best algorithm for diagnosing PE in these patients. In particular, it is not clear how to identify subjects who should undergo computed...

Descripción completa

Detalles Bibliográficos
Autores principales: Porfidia, Angelo, Mosoni, Carolina, Talerico, Rosa, Porceddu, Enrica, Lupascu, Andrea, Tondi, Paolo, Landi, Francesco, Pola, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414135/
https://www.ncbi.nlm.nih.gov/pubmed/34485411
http://dx.doi.org/10.3389/fcvm.2021.714003
_version_ 1783747754898489344
author Porfidia, Angelo
Mosoni, Carolina
Talerico, Rosa
Porceddu, Enrica
Lupascu, Andrea
Tondi, Paolo
Landi, Francesco
Pola, Roberto
author_facet Porfidia, Angelo
Mosoni, Carolina
Talerico, Rosa
Porceddu, Enrica
Lupascu, Andrea
Tondi, Paolo
Landi, Francesco
Pola, Roberto
author_sort Porfidia, Angelo
collection PubMed
description Introduction: Although pulmonary embolism (PE) is a frequent complication of the clinical course of COVID-19, there is a lack of explicit indications regarding the best algorithm for diagnosing PE in these patients. In particular, it is not clear how to identify subjects who should undergo computed tomography pulmonary angiography (CTPA), rather than simply X-ray and/or high resolution computed tomography (HRCT) of the chest. Methods: We retrospectively analyzed COVID-19 patients who presented to the Emergency Department (ED) of our University hospital with acute respiratory failure, or that developed acute respiratory failure during hospital stay, to determine how many of them had a theoretical indication to undergo CTPA for suspected PE according to current guidelines. Next, we looked for differences between patients who underwent CTPA and those who only underwent X-ray and/or HRCT of the chest. Finally, we determined whether patients with a confirmed diagnosis of PE had specific characteristics that made them different from those with a CTPA negative for PE. Results: Out of 93 subjects with COVID-19 and acute respiratory failure, 73 (78.4%) had an indication to undergo CTPA according to the revised Geneva and Wells scores and the PERC rule-out criteria, and 54 (58%) according to the YEARS algorithm. However, in contrast with these indications, only 28 patients (30.1%) underwent CTPA. Of note, they were not clinically different from those who underwent X-ray and/or HRCT of the chest. Among the 28 subjects who underwent CTPA, there were 10 cases of PE (35.7%). They were not clinically different from those with CTPA negative for PE. Conclusions: COVID-19 patients with acute respiratory failure undergo CTPA, X-ray of the chest, or HRCT without an established criterion. Nonetheless, when CTPA is performed, the diagnosis of PE is anything but rare. Validated tools for identifying COVID-19 patients who require CTPA for suspected PE are urgently needed.
format Online
Article
Text
id pubmed-8414135
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84141352021-09-04 Pulmonary Embolism in COVID-19 Patients: Which Diagnostic Algorithm Should We Use? Porfidia, Angelo Mosoni, Carolina Talerico, Rosa Porceddu, Enrica Lupascu, Andrea Tondi, Paolo Landi, Francesco Pola, Roberto Front Cardiovasc Med Cardiovascular Medicine Introduction: Although pulmonary embolism (PE) is a frequent complication of the clinical course of COVID-19, there is a lack of explicit indications regarding the best algorithm for diagnosing PE in these patients. In particular, it is not clear how to identify subjects who should undergo computed tomography pulmonary angiography (CTPA), rather than simply X-ray and/or high resolution computed tomography (HRCT) of the chest. Methods: We retrospectively analyzed COVID-19 patients who presented to the Emergency Department (ED) of our University hospital with acute respiratory failure, or that developed acute respiratory failure during hospital stay, to determine how many of them had a theoretical indication to undergo CTPA for suspected PE according to current guidelines. Next, we looked for differences between patients who underwent CTPA and those who only underwent X-ray and/or HRCT of the chest. Finally, we determined whether patients with a confirmed diagnosis of PE had specific characteristics that made them different from those with a CTPA negative for PE. Results: Out of 93 subjects with COVID-19 and acute respiratory failure, 73 (78.4%) had an indication to undergo CTPA according to the revised Geneva and Wells scores and the PERC rule-out criteria, and 54 (58%) according to the YEARS algorithm. However, in contrast with these indications, only 28 patients (30.1%) underwent CTPA. Of note, they were not clinically different from those who underwent X-ray and/or HRCT of the chest. Among the 28 subjects who underwent CTPA, there were 10 cases of PE (35.7%). They were not clinically different from those with CTPA negative for PE. Conclusions: COVID-19 patients with acute respiratory failure undergo CTPA, X-ray of the chest, or HRCT without an established criterion. Nonetheless, when CTPA is performed, the diagnosis of PE is anything but rare. Validated tools for identifying COVID-19 patients who require CTPA for suspected PE are urgently needed. Frontiers Media S.A. 2021-08-13 /pmc/articles/PMC8414135/ /pubmed/34485411 http://dx.doi.org/10.3389/fcvm.2021.714003 Text en Copyright © 2021 Porfidia, Mosoni, Talerico, Porceddu, Lupascu, Tondi, Landi and Pola. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Porfidia, Angelo
Mosoni, Carolina
Talerico, Rosa
Porceddu, Enrica
Lupascu, Andrea
Tondi, Paolo
Landi, Francesco
Pola, Roberto
Pulmonary Embolism in COVID-19 Patients: Which Diagnostic Algorithm Should We Use?
title Pulmonary Embolism in COVID-19 Patients: Which Diagnostic Algorithm Should We Use?
title_full Pulmonary Embolism in COVID-19 Patients: Which Diagnostic Algorithm Should We Use?
title_fullStr Pulmonary Embolism in COVID-19 Patients: Which Diagnostic Algorithm Should We Use?
title_full_unstemmed Pulmonary Embolism in COVID-19 Patients: Which Diagnostic Algorithm Should We Use?
title_short Pulmonary Embolism in COVID-19 Patients: Which Diagnostic Algorithm Should We Use?
title_sort pulmonary embolism in covid-19 patients: which diagnostic algorithm should we use?
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414135/
https://www.ncbi.nlm.nih.gov/pubmed/34485411
http://dx.doi.org/10.3389/fcvm.2021.714003
work_keys_str_mv AT porfidiaangelo pulmonaryembolismincovid19patientswhichdiagnosticalgorithmshouldweuse
AT mosonicarolina pulmonaryembolismincovid19patientswhichdiagnosticalgorithmshouldweuse
AT talericorosa pulmonaryembolismincovid19patientswhichdiagnosticalgorithmshouldweuse
AT porcedduenrica pulmonaryembolismincovid19patientswhichdiagnosticalgorithmshouldweuse
AT lupascuandrea pulmonaryembolismincovid19patientswhichdiagnosticalgorithmshouldweuse
AT tondipaolo pulmonaryembolismincovid19patientswhichdiagnosticalgorithmshouldweuse
AT landifrancesco pulmonaryembolismincovid19patientswhichdiagnosticalgorithmshouldweuse
AT polaroberto pulmonaryembolismincovid19patientswhichdiagnosticalgorithmshouldweuse